Roivant Sciences Ltd (ROIV)
Healthcare
Biotechnology
33.30 $
-1.7%
vs. previous close
Closing price · As of: 3. Aug 2026
Roivant Sciences Ltd (ROIV) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2026), "Operating Cash Flow" came in at -750 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| -1,024 | -762 | -552 | -678 | -843 | -765 | -839 | -750 | |
| – | 5.9 | 5.9 | 5.9 | 19 | 22 | 14 | 3.3 | |
| 59 | 123 | 85 | 565 | 218 | 200 | 289 | 346 | |
| -31 | -1,972 | 147 | 222 | 276 | – | – | – | |
| 50 | 15 | 72 | 16 | 6.3 | 19 | -77 | -622 | |
| 11 | 4.9 | 5.8 | 17 | 13 | 1.4 | 4.6 | 8.2 | |
| -58 | 1,695 | -32 | 303 | -44 | 5,204 | -1,766 | -682 | |
| – | – | – | – | 163 | 6.0 | – | – | |
| -7.4 | -1,188 | -0.1 | – | 0.3 | 1.0 | -1,293 | -320 | |
| 176 | 52 | 15 | 15 | 130 | -31 | -53 | 0.0 | |
| 767 | 217 | 456 | 307 | 499 | 419 | -1,220 | 134 | |
| 1,119 | 1,336 | -128 | -68 | -382 | 4,858 | -3,825 | -1,295 | |
| -1,036 | -767 | -558 | -695 | -856 | -767 | -844 | -759 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.